Details of issuance or disposal
Issuance of Series 6 Stock Acquisition Rights as paid stock options
5,000,000 shares (50,000 Stock Acquisition Rights, 100 shares per right)
¥5,000,000 (50,000 rights × ¥100)
Approximately 0.98% (relative to 509,156,000 issued shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Series 6 Stock Acquisition Rights as paid stock options |
| Number of shares to be issued or disposed of | 5,000,000 shares (50,000 Stock Acquisition Rights, 100 shares per right) |
| Issue price and disposal price | ¥100 per stock acquisition right |
| Total issue value | ¥5,000,000 (50,000 rights × ¥100) |
| Amount of funds to be raised | Total amount payable: ¥5,000,000. Estimated net proceeds: Not disclosed |
| Payment date | 10 September 2026 |
| Intended allottee | Name Executive officers of the Company (mandate-based) / Number of Employees 2 / Number allocated Not disclosed, Name Employees of the Company / Number of Employees 1 / Number allocated Not disclosed |
| Dilution Rate | Approximately 0.98% (relative to 509,156,000 issued shares) |
| Total number of issued shares | 509,156,000 shares → 514,156,000 shares (if all of these Stock Acquisition Rights are exercised)(Approximately 0.98%) |
| Basis for determining the amount to be paid | ¥100 per Stock Acquisition Right. The amount was determined by reference to the valuation calculated by the third-party valuation firm 株式会社プルータス・コンサルティング using a Monte Carlo simulation and taking share price information and other factors into account. The exercise price of ¥121 is equal to the closing share price of ¥121 on the business day preceding the Board of Directors' resolution date, 31 August 2026. |
| Exercise price | Initial exercise price: ¥121. Adjustment provisions apply in the event of a share split or consolidation, an issuance of shares or disposal of treasury shares below market value, a corporate reorganization or other such event. Floor price: Not disclosed |
| Exercise period | Start Date 1 July 2032 / End date 9 March 2036 |
| Number of Stock Acquisition Rights | Total issued: 50,000 rights. Unexercised balance: Not disclosed |
| Reason for acquisition without consideration | If approval or other authorization is granted for a merger, company split, share exchange, share transfer or similar transaction, or if the Stock Acquisition Rights can no longer be exercised because the exercise conditions are not met, the Company may acquire all unexercised Stock Acquisition Rights without consideration. |
| Categories and Number of Persons Covered | 2 of the Company's executive officers (委任型) and 1 employee. The number of shares allocated to each category: Not disclosed |
| Procedures under the Corporate Code of Conduct | Because the stock acquisition rights will be issued for consideration at fair value and on terms that are not particularly favorable, the issuance will be carried out without shareholder approval. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To motivate and boost the morale of officers and employees toward expanding sales of the AI business, particularly AXON, and maximizing business value, and to strengthen their unity in pursuing medium- to long-term earnings growth and an increase in corporate value.